Rogier R. Press

644 total citations
16 papers, 506 citations indexed

About

Rogier R. Press is a scholar working on Transplantation, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Rogier R. Press has authored 16 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Transplantation, 6 papers in Surgery and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Rogier R. Press's work include Renal Transplantation Outcomes and Treatments (11 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Rogier R. Press is often cited by papers focused on Renal Transplantation Outcomes and Treatments (11 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Rogier R. Press collaborates with scholars based in Netherlands, United States and China. Rogier R. Press's co-authors include Jan den Hartigh, Johan W. de Fijter, Henk‐Jan Guchelaar, Tahar van der Straaten, Bart A. Ploeger, Meindert Danhof, Dirk Jan A. R. Moes, Johannes van Pelt, Jaap Jan Boelens and J. Zwaveling and has published in prestigious journals such as Clinical Chemistry, Fertility and Sterility and Transplantation.

In The Last Decade

Rogier R. Press

16 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rogier R. Press Netherlands 12 300 166 131 101 75 16 506
David Schladt United States 9 380 1.3× 194 1.2× 138 1.1× 59 0.6× 76 1.0× 15 458
W. Guan United States 6 352 1.2× 212 1.3× 96 0.7× 57 0.6× 86 1.1× 8 420
Camille Tron France 16 214 0.7× 149 0.9× 112 0.9× 76 0.8× 145 1.9× 46 568
Casey R. Dorr United States 12 271 0.9× 138 0.8× 91 0.7× 41 0.4× 59 0.8× 29 415
Krzysztof Dziewanowski Poland 12 183 0.6× 98 0.6× 88 0.7× 49 0.5× 32 0.4× 22 359
Mercidita T. Navarro United States 9 646 2.2× 145 0.9× 238 1.8× 63 0.6× 93 1.2× 16 810
Ferdi Sombogaard Netherlands 9 310 1.0× 72 0.4× 58 0.4× 36 0.4× 71 0.9× 14 391
Jean Luc André France 7 192 0.6× 150 0.9× 44 0.3× 41 0.4× 44 0.6× 8 325
Timothy J. Schroeder United States 12 253 0.8× 82 0.5× 143 1.1× 39 0.4× 21 0.3× 19 388
Mingqing Song United States 9 136 0.5× 82 0.5× 141 1.1× 42 0.4× 18 0.2× 19 358

Countries citing papers authored by Rogier R. Press

Since Specialization
Citations

This map shows the geographic impact of Rogier R. Press's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rogier R. Press with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rogier R. Press more than expected).

Fields of papers citing papers by Rogier R. Press

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rogier R. Press. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rogier R. Press. The network helps show where Rogier R. Press may publish in the future.

Co-authorship network of co-authors of Rogier R. Press

This figure shows the co-authorship network connecting the top 25 collaborators of Rogier R. Press. A scholar is included among the top collaborators of Rogier R. Press based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rogier R. Press. Rogier R. Press is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Moes, Dirk Jan A. R., Rogier R. Press, Bart A. Ploeger, et al.. (2016). Exploring genetic and non‐genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients. British Journal of Clinical Pharmacology. 82(1). 227–237. 11 indexed citations
2.
Press, Rogier R., Akin Inderson, Serge C.L.M. Cremers, et al.. (2013). Limited Sampling Model for Advanced Mycophenolic Acid Therapeutic Drug Monitoring After Liver Transplantation. Therapeutic Drug Monitoring. 36(2). 141–147. 20 indexed citations
3.
Moes, Dirk Jan A. R., Rogier R. Press, Jan den Hartigh, et al.. (2012). Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients. Clinical Pharmacokinetics. 51(7). 467–480. 59 indexed citations
4.
Press, Rogier R.. (2011). Individualized dosing of calcineurin inhibitors in renal transplantation. Leiden Repository (Leiden University). 1 indexed citations
5.
Press, Rogier R., Bart A. Ploeger, Jan den Hartigh, et al.. (2010). Explaining variability in ciclosporin exposure in adult kidney transplant recipients. European Journal of Clinical Pharmacology. 66(6). 579–590. 28 indexed citations
6.
Moes, Dirk Jan A. R., Rogier R. Press, Johan W. de Fijter, Henk‐Jan Guchelaar, & Jan den Hartigh. (2010). Liquid Chromatography-Tandem Mass Spectrometry Outperforms Fluorescence Polarization Immunoassay in Monitoring Everolimus Therapy in Renal Transplantation. Therapeutic Drug Monitoring. 32(4). 413–419. 26 indexed citations
7.
Beek, Martha T. van der, Stefan P. Berger, Ann C.T.M. Vossen, et al.. (2010). Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance. Transplantation. 89(3). 320–326. 48 indexed citations
8.
Rossum, Huub H. van, Rogier R. Press, Jan den Hartigh, & Johan W. de Fijter. (2010). Point: A Call for Advanced Pharmacokinetic and Pharmacodynamic Monitoring to Guide Calcineurin Inhibitor Dosing in Renal Transplant Recipients. Clinical Chemistry. 56(5). 732–735. 6 indexed citations
9.
Press, Rogier R., Bart A. Ploeger, Jan den Hartigh, et al.. (2009). Explaining Variability in Tacrolimus Pharmacokinetics to Optimize Early Exposure in Adult Kidney Transplant Recipients. Therapeutic Drug Monitoring. 31(2). 187–197. 114 indexed citations
10.
Bemelman, Fréderike J., et al.. (2009). Minimization of Maintenance Immunosuppression Early After Renal Transplantation: An Interim Analysis. Transplantation. 88(3). 421–428. 48 indexed citations
11.
Willemze, Annemiek, Rogier R. Press, Arjan C. Lankester, et al.. (2009). CsA exposure is associated with acute GVHD and relapse in children after SCT. Bone Marrow Transplantation. 45(6). 1056–1061. 20 indexed citations
12.
Press, Rogier R., Jan den Hartigh, Serge C.L.M. Cremers, et al.. (2008). Flexible Limited Sampling Model for Monitoring Tacrolimus in Stable Patients Having Undergone Liver Transplantation With Samples 4 to 6 Hours After Dosing Is Superior to Trough Concentration. Therapeutic Drug Monitoring. 30(4). 456–461. 12 indexed citations
13.
Zwaveling, J., Rogier R. Press, Robbert G. M. Bredius, et al.. (2008). Glutathione S-transferase Polymorphisms Are Not Associated With Population Pharmacokinetic Parameters of Busulfan in Pediatric Patients. Therapeutic Drug Monitoring. 30(4). 504–510. 73 indexed citations
14.
Hellebrekers, Bart W.J., Trudy C.M. Trimbos-Kemper, Lianne S.M. Boesten, et al.. (2008). Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study): results of a clinical pilot study. Fertility and Sterility. 91(4). 1204–1214. 29 indexed citations
15.
Berge, Ineke J. M. ten, et al.. (2008). MINIMIZATION OF IMMUNOSUPPRESSIVE DRUG THERAPY AT 6 MONTHS AFTER RENAL TRANSPLANTATION: EVEROLIMUS OR CYCLOSPORIN SUPERIOR TO MYCOPHENOLATE SODIUM. Transplantation. 86(2S). 186–186. 2 indexed citations
16.
Press, Rogier R., Tessa Buckle, Jos H. Beijnen, & Olaf van Tellingen. (2005). The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice. Cancer Chemotherapy and Pharmacology. 57(6). 819–825. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Schladt Breakdown of academic impact, for papers by W. Guan Breakdown of academic impact, for papers by Camille Tron Breakdown of academic impact, for papers by Casey R. Dorr Breakdown of academic impact, for papers by Krzysztof Dziewanowski Breakdown of academic impact, for papers by Mercidita T. Navarro Breakdown of academic impact, for papers by Ferdi Sombogaard Breakdown of academic impact, for papers by Jean Luc André Breakdown of academic impact, for papers by Timothy J. Schroeder Breakdown of academic impact, for papers by Mingqing Song
Rankless by CCL
2026